Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Sawai Group Holdings Co Price-to-Tangible-Book Related Terms
Sawai Group Holdings Co Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for Sawai Group Holdings Co's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sawai Group Holdings Co Price-to-Tangible-Book Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Sawai Group Holdings Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sawai Group Holdings Co Price-to-Tangible-Book vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sawai Group Holdings Co's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Sawai Group Holdings Co's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Sawai Group Holdings Co (SWGHF) has a Price-to-Tangible-Book of 1.17 as of Sep. 16, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Sawai Group Holdings Co and its competitors. According to the industry distribution chart, Sawai Group Holdings Co ranks #229 out of 839 companies in the Drug Manufacturers industry, placing it in the top 27.3%.
Is Sawai Group Holdings Co's Price-to-Tangible-Book too high?
Sawai Group Holdings Co's current Price-to-Tangible-Book is 1.17. The Drug Manufacturers industry median Price-to-Tangible-Book is 2.26. Sawai Group Holdings Co's value of 1.17 is 48.2% below this industry median. Based on the distribution chart, Sawai Group Holdings Co ranks #229 out of 839 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Sawai Group Holdings Co has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Sawai Group Holdings Co's Price-to-Tangible-Book compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sawai Group Holdings Co ranks #229 out of 839 companies for Price-to-Tangible-Book. This puts Sawai Group Holdings Co in the upper half of its industry. The industry median Price-to-Tangible-Book is 2.26. Sawai Group Holdings Co's value of 1.17 is 48.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Drug Manufacturers company?
The median Price-to-Tangible-Book among Drug Manufacturers companies is 2.26, based on 839 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sawai Group Holdings Co's current Price-to-Tangible-Book of 1.17 is 48.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Sawai Group Holdings Co and its competitors. For the Drug Manufacturers industry, the median Price-to-Tangible-Book is 2.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sawai Group Holdings Co's current Price-to-Tangible-Book is 1.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sawai Group Holdings Co stock overvalued right now?
Sawai Group Holdings Co (SWGHF) has a current Price-to-Tangible-Book of 1.17. The stock's GF Value™ is $16.91, compared to a current price of $11.52 — trading 31.9% below its estimated fair value. The current Price-to-Tangible-Book is 1.17 and 48.2% below the Drug Manufacturers industry median of 2.26. Sawai Group Holdings Co's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For Sawai Group Holdings Co (SWGHF), the current Price-to-Tangible-Book is 1.17 as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sawai Group Holdings Co (SWGHF) Overvalued in 2026?
Based on GuruFocus' analysis, Sawai Group Holdings Co stock appears to be undervalued.
The current stock price of $11.52 is trading 31.9% below its estimated GF Value™ of $16.91.
Key valuation signals for SWGHF:
Price-to-Tangible-Book: 1.17
GF Value™: $16.91 vs. price of $11.52 (31.9% below fair value)
Industry Position: 48.2% below the Drug Manufacturers median (#229 of 839)
No single metric tells the full story. See the SWGHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sawai Group Holdings Co Ltd is engaged in providing management support or guidance to domestic and foreign companies engaged in businesses related to medical and healthcare services, such as the manufacture and sale of pharmaceutical products and medical equipment, as well as various businesses incidental or related to the same.
52GF Score
Get the complete analysis for SWGHF
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SWGHF has been successfully added to your 
